The U.S. Food and Drug Administration approved an Investigational New Drug (IND) application using efficacy data solely from ...
PainReform has released details on, and the commencement of, its development plan for OcuRing-K, including an upcoming phase 2 clinical trial. 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback